AHL
RVMD icon

Abel Hall LLC’s Revolution Medicines RVMD Stock Holding History

Abel Hall LLC’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Sell
5,394
-448
-8% -$65.4K 0.17% 82
2026
Q1 		$568K Buy
5,842
+334
+6% +$33.7K 0.12% 156
2025
Q4 		$439K Buy
+5,508
New +$361K 0.1% 209

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Abel Hall LLC's RVMD Position: Q2 2026 in Review

Abel Hall LLC reduced its Revolution Medicines (RVMD) stake by 7.7% in Q2 2026, selling an estimated $65.4K and leaving 5,394 shares worth $1.01M. The position accounts for 0.17% of the portfolio, ranked #82.

Abel Hall LLC first reported a position in RVMD in Q4 2025 and has held it in 3 quarters since. 692 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Abel Hall LLC held 5,394 shares of Revolution Medicines worth $1.01M as of Q2 2026.
  • Abel Hall LLC sold 448 Revolution Medicines shares in Q2 2026, an estimated $65.4K.
  • Revolution Medicines made up 0.17% of Abel Hall LLC's portfolio in Q2 2026, its #82 holding.
  • Abel Hall LLC first reported a position in Revolution Medicines in Q4 2025 and has held it in 3 quarters since.
  • 692 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.